Logo image of PRM

PERIMETER SOLUTIONS INC (PRM) Stock Fundamental Analysis

NYSE:PRM - US71385M1071 - Common Stock

19.48 USD
+0.79 (+4.23%)
Last: 8/22/2025, 8:04:01 PM
19.48 USD
0 (0%)
After Hours: 8/22/2025, 8:04:01 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PRM. PRM was compared to 84 industry peers in the Chemicals industry. PRM has an average financial health and profitability rating. PRM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

PRM had negative earnings in the past year.
PRM had a positive operating cash flow in the past year.
In multiple years PRM reported negative net income over the last 5 years.
PRM had a positive operating cash flow in 4 of the past 5 years.
PRM Yearly Net Income VS EBIT VS OCF VS FCFPRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

PRM has a Return On Assets of 3.20%. This is in the better half of the industry: PRM outperforms 66.67% of its industry peers.
PRM's Return On Equity of 6.75% is fine compared to the rest of the industry. PRM outperforms 70.24% of its industry peers.
PRM has a Return On Invested Capital of 2.58%. This is in the lower half of the industry: PRM underperforms 61.90% of its industry peers.
Industry RankSector Rank
ROA 3.2%
ROE 6.75%
ROIC 2.58%
ROA(3y)2.14%
ROA(5y)-3.4%
ROE(3y)4.47%
ROE(5y)-7.84%
ROIC(3y)N/A
ROIC(5y)N/A
PRM Yearly ROA, ROE, ROICPRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

PRM's Profit Margin of 13.05% is amongst the best of the industry. PRM outperforms 91.67% of its industry peers.
With a decent Operating Margin value of 12.75%, PRM is doing good in the industry, outperforming 69.05% of the companies in the same industry.
PRM's Gross Margin of 57.90% is amongst the best of the industry. PRM outperforms 98.81% of its industry peers.
In the last couple of years the Gross Margin of PRM has grown nicely.
Industry RankSector Rank
OM 12.75%
PM (TTM) 13.05%
GM 57.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.47%
GM growth 5Y10.02%
PRM Yearly Profit, Operating, Gross MarginsPRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRM is destroying value.
The number of shares outstanding for PRM has been increased compared to 1 year ago.
Compared to 5 years ago, PRM has less shares outstanding
PRM has a better debt/assets ratio than last year.
PRM Yearly Shares OutstandingPRM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PRM Yearly Total Debt VS Total AssetsPRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

PRM has an Altman-Z score of 1.49. This is a bad value and indicates that PRM is not financially healthy and even has some risk of bankruptcy.
PRM's Altman-Z score of 1.49 is on the low side compared to the rest of the industry. PRM is outperformed by 65.48% of its industry peers.
The Debt to FCF ratio of PRM is 5.11, which is a neutral value as it means it would take PRM, 5.11 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 5.11, PRM belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
PRM has a Debt/Equity ratio of 0.67. This is a neutral value indicating PRM is somewhat dependend on debt financing.
The Debt to Equity ratio of PRM (0.67) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 5.11
Altman-Z 1.49
ROIC/WACC0.3
WACC8.67%
PRM Yearly LT Debt VS Equity VS FCFPRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.04 indicates that PRM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.04, PRM belongs to the top of the industry, outperforming 88.10% of the companies in the same industry.
PRM has a Quick Ratio of 2.60. This indicates that PRM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.60, PRM belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.04
Quick Ratio 2.6
PRM Yearly Current Assets VS Current LiabilitesPRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

PRM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.00%, which is quite impressive.
The Revenue has grown by 56.85% in the past year. This is a very strong growth!
Measured over the past years, PRM shows a quite strong growth in Revenue. The Revenue has been growing by 18.58% on average per year.
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%178.57%
Revenue 1Y (TTM)56.85%
Revenue growth 3Y15.69%
Revenue growth 5Y18.58%
Sales Q2Q%27.78%

3.2 Future

PRM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.08% yearly.
Based on estimates for the next years, PRM will show a small growth in Revenue. The Revenue will grow by 3.43% on average per year.
EPS Next Y215.98%
EPS Next 2Y81.92%
EPS Next 3Y51.08%
EPS Next 5YN/A
Revenue Next Year0.12%
Revenue Next 2Y2.69%
Revenue Next 3Y3.43%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PRM Yearly Revenue VS EstimatesPRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
PRM Yearly EPS VS EstimatesPRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

4

4. Valuation

4.1 Price/Earnings Ratio

PRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 16.35, PRM is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PRM is on the same level as its industry peers.
PRM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.82.
Industry RankSector Rank
PE N/A
Fwd PE 16.35
PRM Price Earnings VS Forward Price EarningsPRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRM indicates a slightly more expensive valuation: PRM is more expensive than 75.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PRM is valued a bit cheaper than the industry average as 72.62% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.44
EV/EBITDA 24.08
PRM Per share dataPRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PRM's earnings are expected to grow with 51.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.92%
EPS Next 3Y51.08%

0

5. Dividend

5.1 Amount

No dividends for PRM!.
Industry RankSector Rank
Dividend Yield N/A

PERIMETER SOLUTIONS INC

NYSE:PRM (8/22/2025, 8:04:01 PM)

After market: 19.48 0 (0%)

19.48

+0.79 (+4.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners84.97%
Inst Owner Change3%
Ins Owners8.61%
Ins Owner Change4.76%
Market Cap2.85B
Analysts80
Price Target19.38 (-0.51%)
Short Float %3.3%
Short Ratio3.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.87%
Min EPS beat(2)45.71%
Max EPS beat(2)98.02%
EPS beat(4)3
Avg EPS beat(4)65.41%
Min EPS beat(4)-196.63%
Max EPS beat(4)314.52%
EPS beat(8)6
Avg EPS beat(8)111.43%
EPS beat(12)9
Avg EPS beat(12)153.12%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.2%
Min Revenue beat(2)-4.91%
Max Revenue beat(2)15.31%
Revenue beat(4)2
Avg Revenue beat(4)5.06%
Min Revenue beat(4)-4.91%
Max Revenue beat(4)15.31%
Revenue beat(8)5
Avg Revenue beat(8)16.22%
Revenue beat(12)8
Avg Revenue beat(12)12.54%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.7%
PT rev (3m)18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.43%
EPS NY rev (1m)5.03%
EPS NY rev (3m)5.03%
Revenue NQ rev (1m)-7.5%
Revenue NQ rev (3m)-12.3%
Revenue NY rev (1m)0.45%
Revenue NY rev (3m)5.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.35
P/S 4.68
P/FCF 18.44
P/OCF 14.42
P/B 2.42
P/tB N/A
EV/EBITDA 24.08
EPS(TTM)-0.06
EYN/A
EPS(NY)1.19
Fwd EY6.12%
FCF(TTM)1.06
FCFY5.42%
OCF(TTM)1.35
OCFY6.94%
SpS4.16
BVpS8.05
TBVpS-5.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.2%
ROE 6.75%
ROCE 3.26%
ROIC 2.58%
ROICexc 2.74%
ROICexgc 21.03%
OM 12.75%
PM (TTM) 13.05%
GM 57.9%
FCFM 25.39%
ROA(3y)2.14%
ROA(5y)-3.4%
ROE(3y)4.47%
ROE(5y)-7.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.47%
GM growth 5Y10.02%
F-Score9
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 5.11
Debt/EBITDA 5.43
Cap/Depr 63.66%
Cap/Sales 7.08%
Interest Coverage 1.95
Cash Conversion 136.06%
Profit Quality 194.56%
Current Ratio 4.04
Quick Ratio 2.6
Altman-Z 1.49
F-Score9
WACC8.67%
ROIC/WACC0.3
Cap/Depr(3y)17.09%
Cap/Depr(5y)16.01%
Cap/Sales(3y)2.7%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%178.57%
EPS Next Y215.98%
EPS Next 2Y81.92%
EPS Next 3Y51.08%
EPS Next 5YN/A
Revenue 1Y (TTM)56.85%
Revenue growth 3Y15.69%
Revenue growth 5Y18.58%
Sales Q2Q%27.78%
Revenue Next Year0.12%
Revenue Next 2Y2.69%
Revenue Next 3Y3.43%
Revenue Next 5YN/A
EBIT growth 1Y166.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.48%
EBIT Next 3Y15.58%
EBIT Next 5YN/A
FCF growth 1Y572.59%
FCF growth 3Y40.29%
FCF growth 5YN/A
OCF growth 1Y932.76%
OCF growth 3Y37.57%
OCF growth 5YN/A